Correction: Preferential site substitution of Eu3+ ions in Ca10(PO4)6Cl2 nanoparticles obtained usinga microwave stimulated wet chemistry technique

International audience“In accordance with the rule of 2J + 1 at Cs symmetry a maximum of five sublevels should be present for the 5D0 → 7F1 andeight in the case of the 5D0 → 7F2 transitions whereas at C3 symmetry the 5D0 → 7F1 splits into two and the 5D0 → 7F2 into threeStark components.”Should have read:In accordance with the rule of 2J + 1 at Cs symmetry a maximum of three sublevels should be present for the 5D0 → 7F1 andfive in the case of the 5D0 → 7F2 transitions whereas at C3 symmetry the 5D0 → 7F1 splits into two and the 5D0 → 7F2 into threeStark components.The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.2780

Screening and diagnosis for mood and anxiety disorders in epilepsy: Polish population reference values

Introduction. Epilepsy is one of the world’s most prevalent noncommunicable diseases and tends to have a chronic course, often with comorbid psychiatric disorders, of which depressive disorders (DDs) and anxiety disorders (ADs) are the most common.Background. As anxiety and depressive disorders are underdiagnosed and so undertreated in people with epilepsy (PWE), this could have implications for the course of both of these medical conditions and the response to treatment and health outcomes. Thus it is crucial to perform screening for psychiatric disorders in populations with epilepsy using specific psychometric screening instruments optimised for that group of patients. Polish versions of the Hospital Anxiety and Depression Scale (HADS), the Hamilton Rating Scale for Depression (HRSD), the Hamilton Anxiety Rating Scale (HARS), the Beck Depression Inventory (BDI), the State-Trait Anxiety Inventory (STAI) and the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) were validated against ‘gold standards’ in a Polish population with epilepsy.Clinical implications. Using well-validated screening instruments that can be easily implemented in a clinical setting may contribute to better diagnosis, and consequently treatment, of comorbid psychiatric disorders, which would have a great impact on the course and prognosis of epilepsy management. Conclusions. Based on the outcomes of Polish studies aimed at validating psychometric instruments for screening for mood and anxiety disorders, HADS is recommended as a first-choice screening tool

Correction: Effects of crystalline growth on structural and luminescence properties of Ca (10−3x) Eu 2x (PO 4 ) 6 F 2 nanoparticles fabricated by using a microwave driven hydrothermal process

International audienc

[Intravenous clomipramine for depressive disorders].

51 patients with depressive episode (40--recurrent depressive disorder, 11--bipolar affective disorder) were treated by the clomipramine intravenous infusions. The number of infusions varied from 5 to 21 (mostly 10-16). The median of maximal dose was 150 mg. There were significant clinical improvement measured by CGI. The therapy was well tolerated

The f-f Emission of Pr3+ Ion as an Optical Probe for the Structural Properties of YAG Nanoceramics

Transparent Pr-doped YAG nanocerainics composed of grains with an average size of 42 nm, were fabricated with the Low Temperature Hight Pressure (LTHP) sintering technique using the corresponding nanopowders as the starting materials. The structure of the nanoceramics was analyed by X-ray diffraction (XRD). The effect of the sintering conditions on the structural properties is discussed on the basis of the changes of the spectroscopic properties of Pr3+. In particular, the intensities and decays of the emission transitions originating from the P-3(0) and D-1(2) levels are investigated and correlated with structural properties of the material, such as microstrains produced by the high-pressure process